… marketed Duchenne muscular dystrophy drugs failed to reach its … In addition to approving drugs with limited or questionable … controversy. Biogen and Eisai’s Alzheimer’s drug Aduhelm, for … , biologics and other specialty drugs can bankrupt families,” he …

… Eli Lilly’s Kisunla and Eisai and Biogen’s Leqembi have … , reflecting the novelty of the drugs’ mechanism. The approved amyloid-targeting … risk of ARIA without reducing drug dosage. “I expect that … those who started taking the drug later. But the steady rise …

… of Eisai's MSD-partnered cancer drug Lenvima … not been disclosed. Eisai has already reached settlement … something happens to overturn Eisai's patent protection … drug to its blockbuster cancer immunotherapy Keytruda (pembrolizumab). According to Eisai …

… their 2020 partnership. The drug is designed to damage … session in the New Drugs on the Horizon series … of Emerging WRN Inhibitors Drugs Competitive Intelligence Analysis: SWOT … Roche, Iovance Biotherapeutics, GSK, Eisai, among others. Mismatch Repair …

… Recent Industry Developments ✅ October 2025: Eisai Co. launched innovative treatment candidates … regulatory incentives accelerate novel drug development pipelines targeting MASH … and immune modulation. Antifibrotic drugs are rapidly growing, aimed …

… of its Investigational New Drug (IND) application for … collaborators, including Lilly and Eisai, and clinicians from leading … primarily due to higher drug manufacturing expenses, higher professional … primarily due to higher drug manufacturing expenses, higher …

… has cleared the Investigational New Drug (IND) application for ST- … enables the discovery of drug-like molecular glues for … candidate and has received Orphan Drug and Rare Pediatric Disease … ligase biology Eli Lilly and Eisai are cornerstone investors and …

… director of the phase I drug development clinical program at the … Myers Squibb, Roche/Genentech, Eisai, Merck, Agenus, Exelixis, AstraZeneca… with Bristol Myers Squibb, Bayer, Eisai, Roche, Merck, Exelixis, Pieris Pharmaceuticals …

… The U.S. Food and Drug Administration (FDA) has approved … kinase inhibitor discovered by Eisai. This is the first … plus LENVIMA in collaboration with Eisai Co., Ltd. Together, the … , RNA and protein analysis; drug development; human identification and molecular …

… innovations in therapeutic applications and drug delivery systems. Explore trends before … ongoing clinical research focuses on drug dosage escalation, intravitreal implants, … , Bayer, Roche, Amgen, Eli Lilly, Eisai, Sino Pharma, and Takeda, are …